- home
- article
- AstraZeneca to Withdraw Covid Vaccine Globally Due to Decline in Demand
AstraZeneca to Withdraw Covid Vaccine Globally Due to Decline in Demand
ai generated text
AstraZeneca has announced the global withdrawal of its Covid-19 vaccine, citing a "surplus of available updated vaccines" as the reason. The European Commission had previously withdrawn marketing authorisation for Vaxzevria in March, and the withdrawal became effective on Tuesday. The company had also admitted that the vaccine causes side effects, which may have contributed to a decline in demand. Notably, the vaccine has not been available in Australia since March 2023.
As multiple, variant COVID-19 vaccines have since been developed, there is a surplus of available updated vaccines.
It is admitted that the AZ vaccine can, in very rare cases, cause TTS. The causal mechanism is not known.
From the body of evidence in clinical trials and real-world data, the AstraZeneca-Oxford vaccine has continuously been shown to have an acceptable safety profile and regulators around the world consistently state that the benefits of vaccination outweigh the risks of extremely rare potential side effects.
Our sympathy goes out to anyone who has lost loved ones or reported health problems. Patient safety is our highest priority, and regulatory authorities have clear and stringent standards to ensure the safe use of all medicines, including vaccines.
Covid-19 Pandemic
- White House website blames China for Covid-19 "lab leak"
- CIA officials express likelihood of COVID-19 virus originating from laboratory leak
- Dr Fauci No Longer Receives Presidential Protection Amid Death Threats
sources
perspectives
- 1.Chinese Foreign Policy
- 2.US-China Relations
- 3.China under Xi Jinping
- 4.World Economy
- 5.Healthcare
- 6.Vaccination
- 7.Pandemic
- 8.Covid-19 Pandemic
countries
organizations
- 1.AstraZeneca
- 2.Australian Technical Advisory Group on Immunisation
- 3.Covishield
- 4.European Commission
- 5.European Union
- 6.Serum Institute of India
- 7.SII
- 8.Therapeutic Goods Administration
- 9.University of Oxford